This year’s top 5 most-viewed videos include topics on eosinophilic esophagitis (EoE), cancer screening awareness, and racial/ethnic and socioeconomic barriers to care.
The top 5 most-viewed videos in 2022 on AJMC.com covered topics on eosinophilic esophagitis (EoE) education and awareness, improvements in cancer screening, and identifying racial and ethnic disparities.
Here are the top 5 videos interviews in 2022.
5. Dr Debra Patt Addresses the Importance of Cancer Screening Awareness, Strong Health Care Infrastructure
Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, spoke on how oncology outreach efforts have been effective in getting patients to come back, and the challenges in health care that still need to be overcome. Understaffing and a nursing shortage since the COVID-19 pandemic has exacerbated these challenges, she said.
4. Dr Victoria Ly Outlines Potential Future Research on Vision Screening Follow-up Disparities
Victoria Ly, MD, MPH, conducted a literature review that showed parents perceived affordability as a barrier to follow-up eye care, and suggested increasing Children's Health Insurance Program’s (CHIP) enrollment to help lessen this burden. She also spoke about future research, which would report demographics and socioeconomic background to help guide key policy makers.
3. EoE Affects Many Aspects of a Child's Quality of Life, Advocate Says
Colette Romero is an advocate for EoE awareness. As a mother of a son with EoE, Romero spoke about the challenges of EoE that have affected her son’s quality of life. Those challenges include hospital visits, malnutrition, having a very limited diet, social issues, and more.
2. EoE Advocate Colette Romero on Need for More Physician Education About Eosinophilic Disorders
In this interview, Romero spoke about how primary care providers need more education on EoE, since they are often the first to see a child with EoE symptoms. Gastroenterologists need more education and awareness as well. EoE is still a relatively new disease, and there are more treatment options available.
1. Dr Debra Patt on Capturing the HER2-Low Population
In this interview, Patt spoke on findings of DESTINY-Breast04. What this study showed is that low-patient HER-2 populations may have a better survival benefit from being treated with trastuzumab deruxtecan in comparison to chemotherapy.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More